Bruker Corporation (BRKR) is a publicly traded Healthcare sector company. As of August 26, 2026, BRKR trades at $56.91 with a market cap of $8.68B and a P/E ratio of -81.87. BRKR moved -0.16% today. Year to date, BRKR is +18.17%; over the trailing twelve months it is +64.26%. Its 52-week range spans $28.53 to $65.30. Analyst consensus is buy with an average price target of $55.75. Rallies surfaces BRKR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
10 analysts cover BRKR: 0 strong buy, 5 buy, 4 hold, 1 sell, and 0 strong sell. The consensus rating is buy. The average price target is $55.75.
| Metric | Value |
|---|---|
| Price | $56.91 |
| Market Cap | $8.68B |
| P/E Ratio | -81.87 |
| EPS | $-0.70 |
| Dividend Yield | 0.05% |
| 52-Week High | $65.30 |
| 52-Week Low | $28.53 |
| Volume | 613.46K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.50B |
| Net Income | $-64.50M |
| Gross Margin | 46.42% |
10 analysts cover BRKR: 0 strong buy, 5 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $55.75.